unknown
Stage
About
Intabio develops a molecular diagnostic platform leveraging CRISPR and synthetic biology to enable point-of-care diagnostics.
Explore Intabio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.